These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32382137)

  • 1. Transcriptomic signatures of treatment response to the combination of escitalopram and memantine or placebo in late-life depression.
    Grzenda A; Siddarth P; Laird KT; Yeargin J; Lavretsky H
    Mol Psychiatry; 2021 Sep; 26(9):5171-5179. PubMed ID: 32382137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized Double-Blind Placebo-Controlled Trial of Combined Escitalopram and Memantine for Older Adults With Major Depression and Subjective Memory Complaints.
    Lavretsky H; Laird KT; Krause-Sorio B; Heimberg BF; Yeargin J; Grzenda A; Wu P; Thana-Udom K; Ercoli LM; Siddarth P
    Am J Geriatr Psychiatry; 2020 Feb; 28(2):178-190. PubMed ID: 31519517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence.
    Muhonen LH; Lönnqvist J; Juva K; Alho H
    J Clin Psychiatry; 2008 Mar; 69(3):392-9. PubMed ID: 18348597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined treatment with escitalopram and memantine increases gray matter volume and cortical thickness compared to escitalopram and placebo in a pilot study of geriatric depression.
    Krause-Sorio B; Siddarth P; Kilpatrick L; Laird KT; Milillo MM; Ercoli L; Narr KL; Lavretsky H
    J Affect Disord; 2020 Sep; 274():464-470. PubMed ID: 32663977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of alcohol dependence in patients with co-morbid major depressive disorder--predictors for the outcomes with memantine and escitalopram medication.
    Muhonen LH; Lahti J; Sinclair D; Lönnqvist J; Alho H
    Subst Abuse Treat Prev Policy; 2008 Oct; 3():20. PubMed ID: 18834506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memantine can protect against inflammation-based cognitive decline in geriatric depression.
    Van Dyk K; Siddarth P; Rossetti M; Ercoli LM; Milillo MM; Lavretsky H
    Brain Behav Immun Health; 2020 Dec; 9():100167. PubMed ID: 34589902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, 6-week prospective pilot study on the efficacy and safety of dose escalation in non-remitters in comparison to those of the standard dose of escitalopram for major depressive disorder.
    Kim EY; Kim SH; Lee HJ; Lee NY; Kim HY; Park CHK; Ahn YM
    J Affect Disord; 2019 Dec; 259():91-97. PubMed ID: 31445345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escitalopram for severe asthma and major depressive disorder: a randomized, double-blind, placebo-controlled proof-of-concept study.
    Brown ES; Howard C; Khan DA; Carmody TJ
    Psychosomatics; 2012; 53(1):75-80. PubMed ID: 22221724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
    Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional White Matter Integrity Predicts Treatment Response to Escitalopram and Memantine in Geriatric Depression: A Pilot Study.
    Krause-Sorio B; Siddarth P; Milillo MM; Vlasova R; Ercoli L; Narr KL; Lavretsky H
    Front Psychiatry; 2020; 11():548904. PubMed ID: 33329088
    [No Abstract]   [Full Text] [Related]  

  • 12. Age at onset of first depressive episode as a predictor for escitalopram treatment of major depression comorbid with alcohol dependence.
    Muhonen LH; Lönnqvist J; Lahti J; Alho H
    Psychiatry Res; 2009 May; 167(1-2):115-22. PubMed ID: 19346004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
    Waugh J; Goa KL
    CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward a neuroimaging treatment selection biomarker for major depressive disorder.
    McGrath CL; Kelley ME; Holtzheimer PE; Dunlop BW; Craighead WE; Franco AR; Craddock RC; Mayberg HS
    JAMA Psychiatry; 2013 Aug; 70(8):821-9. PubMed ID: 23760393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].
    Azorin JM; Llorca PM; Despiegel N; Verpillat P
    Encephale; 2004; 30(2):158-66. PubMed ID: 15107719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder.
    Colonna L; Andersen HF; Reines EH
    Curr Med Res Opin; 2005 Oct; 21(10):1659-68. PubMed ID: 16238906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder.
    Lepola U; Wade A; Andersen HF
    Int Clin Psychopharmacol; 2004 May; 19(3):149-55. PubMed ID: 15107657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined treatment with memantine/es-citalopram for older depressed patients with cognitive impairment: a pilot study.
    Pelton GH; Harper OL; Roose SP; Marder K; D'Antonio K; Devanand DP
    Int J Geriatr Psychiatry; 2016 Jun; 31(6):648-55. PubMed ID: 26559790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of depression with escitalopram in patients undergoing treatment for head and neck cancer: randomized, double-blind, placebo-controlled clinical trial.
    Lydiatt WM; Bessette D; Schmid KK; Sayles H; Burke WJ
    JAMA Otolaryngol Head Neck Surg; 2013 Jul; 139(7):678-86. PubMed ID: 23788218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of agomelatine and escitalopram on depression, subjective sleep and emotional experiences in patients with major depressive disorder: a 24-wk randomized, controlled, double-blind trial.
    Corruble E; de Bodinat C; Belaïdi C; Goodwin GM;
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2219-34. PubMed ID: 23823799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.